PATHWAY CAPITAL MANAGEMENT, LP

PATHWAY CAPITAL MANAGEMENT, LP latest Q4_2020 13F filings reported $1,280,000 in market value on this 2021-02-10 report date . The portfolio quarterly return is -98.86%. This fund has 2 securities concentrations of 100% weights.

PATHWAY CAPITAL MANAGEMENT, LP largest holding is Mersana Therapeutics Inc. with weight of 84.38% and $1,080,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-102020-12-31Q4_202013F-HR2$1,280,000-98.86%
2020-11-122020-09-30Q3_202013F-HR3$111,987,000-12.90%
2020-08-122020-06-30Q2_202013F-HR1$128,579,00012.02%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
MERSANA THERAPEUTICS INCMRSNBUY$1,0800.00%84.38%$26.600.00%40,600
QUANTERIX CORPQTRXBUY$2000.00%15.63%$46.510.00%4,300
DATADOG INCDDOGSOLD$00.00%-100.00%$0.000.00%0
DYNATRACE INCDTSOLD$00.00%-100.00%$0.000.00%0
PHREESIA INCPHRSOLD$00.00%-100.00%$0.000.00%0